BEVAREST-100 INJECTION 4 ML

BEVAREST-100 INJECTION 4 ML is a recombinant monoclonal antibody that belongs to the immunotherapy class of cancer treatment. It can either be used as monotherapy or in combination with chemotherapy or immunotherapy medications to improve the overall survival rate.

While for women with reproductive potential subjected to BEVAREST-100 INJECTION 4 ML, it is advised to discuss with your doctor regarding the effective birth control methods during the treatment. Also to be continued for a minimum of 6 months after the treatment course completion as this medicine may impair fertility.

BEVAREST-100 INJECTION 4 ML is associated with increased risk of bleeding complications and poor wound healing. Hence it is suggested to avoid planning for surgery and maintain an interval of 28days before or after surgery.

All the side effects that are relatively caused by BEVAREST-100 INJECTION 4 ML occur until the drug concentration stays in the body. It is found that this medicine will be contained in our body for almost 4 months after the final dose.

BEVAREST-100 INJECTION 4 ML is given intravenously through infusion and the amount of drug will be measured based on the patient’s body weight, height and age. The first dose will be administered for 90 minutes and if well tolerated the infusion time can be reduced to 30 minutes.

Inform your physician before starting your treatment with BEVAREST-100 INJECTION 4 ML in case, if you are pregnant or planning for pregnancy as this medicine may cause harm to the unborn baby and interrupt the formation of blood vessels.

There are no known interactions of BEVAREST-100 INJECTION 4 ML with other drugs.

Inform your physician if you have conditions involving inflammation in the stomach (ulcer, colitis), experience allergic reactions to BEVAREST-100 INJECTION 4 ML or its ingredients, have recently undergone surgery as it is associated with the risk of bleeding, or have diabetes, hypertension, or heart problems.

BEVACIZUMAB is the molecule/combination used for making BEVAREST-100 INJECTION 4 ML.

BEVAREST-100 INJECTION 4 ML is used to treat various types of cancers such as colorectal cancer, lung cancer, kidney cancer, ovarian cancer, and cervical cancer.

BEVAREST-100 INJECTION 4 ML may be associated with risks such as bleeding, blood clots, high blood pressure, and impaired wound healing.